Conditions: Diabetes Mellitus, Type 2
Keywords: diabetes type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 471
Healthy volunteers: no

Brief summary:
The purpose of this study is to examine the effectiveness and safety of insulin lispro protamine suspension (ILPS) as compared to insulin glargine as basal insulin therapy in adults with type 2 diabetes.

Detailed description:

Arms:
arm 1: Insulin Lispro protamine suspension: Patient adjusted dose, once daily (QD) or twice daily (BID), injected subcutaneous (SC) x 24 weeks arm 2: Insulin glargine: Patient adjusted dose, once daily (QD), injected subcutaneous (SC) x 24 weeks

Interventions: intervention 1: Insulin Lispro Protamine Suspension intervention 2: Insulin Glargine
Intervention descriptions: intervention 1: Patient adjusted dose, once daily (QD) or twice daily (BID), injected subcutaneous (SC) x 24 weeks intervention 2: Patient adjusted dose, once daily (QD), injected subcutaneous (SC) x 24 weeks

Protocol document: